RESET-INSPIRE Study: Insulin Sensitivity & Population Intervention With Real-time Evaluation Using CGM

Más betegség

• Known diagnosis of diabetes mellitus (type 1 or type 2), or use of antidiabetic medication.
• Known history of liver disease or abnormal liver function deemed clinically significant by the investigator who is a medical doctor.
• Known allergy or intolerance to CGM adhesives or inability to comply with CGM sensor placement, or
• Any medical, psychiatric, or social condition that, in the opinion of the investigator, would interfere with the participant's ability to adhere to study procedures or would pose additional risk.

Laborértékek

• Current or recent (within 3 months) use of medications known to affect glucose, including but not limited to corticosteroids.
• Renal impairment, defined as eGFR ≤ 60mL/min/1.73m\^2

Egyéb

• Known pregnancy, plans to become pregnant during the study period, or currently breastfeeding, or
• Participation in another interventional clinical trial within the past 3 months.

• Adults aged between 21 and 70 years (including 70 yrs old) at the time of screening
• Able to speak and understand English
• No past history of acute myocardial infarction (heart attack), stroke or heart failure
• Able to understand and voluntarily provide written informed consent prior to any study specific procedures.
• No current diagnosis of type 1 or type 2 diabetes, and not taking glucose-lowering medications.
• Willing and able to comply with all scheduled study procedures.